600161
vs
GILD
600161
GILD
Over the past 12 months, Beijing Tiantan Biological Products Corp Ltd has underperformed GILD, delivering a return of -21% compared to the GILD's +29% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
600161
GILD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Intrinsic Value
21.94
CNY
Undervaluation 27%
GILD
Intrinsic Value
118.5
USD
Overvaluation 18%
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
|
16.04
CNY
|
|||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
145.21
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
600161, GILD
600161, GILD
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Beijing Tiantan Biological Products Corp Ltd
Revenue
|
|||||||||||
|
|
Gilead Sciences Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
600161, GILD
600161, GILD
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
|
|||||||||
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Beijing Tiantan Biological Products Corp Ltd
45.6%
GILD
78.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
Operating Margin
Beijing Tiantan Biological Products Corp Ltd
33.1%
GILD
40%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
Net Margin
Beijing Tiantan Biological Products Corp Ltd
20.5%
GILD
28.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
FCF Margin
Beijing Tiantan Biological Products Corp Ltd
-17.8%
GILD
32.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROE
Beijing Tiantan Biological Products Corp Ltd
11.9%
GILD
40.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROA
Beijing Tiantan Biological Products Corp Ltd
8.2%
GILD
14.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROIC
Beijing Tiantan Biological Products Corp Ltd
14%
GILD
21.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROCE
Beijing Tiantan Biological Products Corp Ltd
14.6%
GILD
25%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Beijing Tiantan Biological Products Corp Ltd | ||||
|
|
Gilead Sciences Inc | ||||
Solvency Comparison
Beijing Tiantan Biological Produ...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
600161, GILD
600161, GILD
Performance Gap
600161, GILD
600161, GILD
Performance By Year
600161, GILD
600161, GILD
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 600161 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Beijing Tiantan Biological Pro...
ABBV
Abbvie Inc
More expensive
vs Beijing Tiantan Biological Pro...
AMGN
Amgen Inc
More expensive
vs Beijing Tiantan Biological Pro...
VRTX
Vertex Pharmaceuticals Inc
More expensive
vs Beijing Tiantan Biological Pro...
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
